Author: Nichols Martin|| Date Published: July 8, 2020
Advanced Technology International has been awarded a one-year, $450.4M contract modification by the U.S. Army to produce antibodies to the virus that causes COVID-19.
The branch obligated the full contract amount for ATI’s large-scale antibody manufacturing efforts, the Department of Defense said Tuesday.
Work will take place in Summerville, S.C., and Tarrytown, N.Y., through June 30 next year.
ATI operates as a nonprofit subsidiary of ANSER and serves government customers through research-and-development collaboratins.
Former CACI International executive Jeffrey Keen has been named senior vice president of federal civilian programs at defense and national security company Xcelerate Solutions.…
Pradeep Paruchuri, senior director of solutions engineering at UiPath, said agentic artificial intelligence could help government agencies improve efficiency by…